Ben Keeton, of the Kentucky BioAlliance, joins in on the State of Affairs show on station WFPL, Louisville’s NPR News station.  On the program, biotech insiders look at Biotechnology, Biologistics, and Biobusiness in Kentucky.  The show first asks “What is biotechnology?” and then they ask the experts to explain the what, why and how of […]

President Barack Obama has announced his intent to nominate David J. Kappos as Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office. According to the press release: Mr. Kappos is Vice President and Assistant General Counsel, Intellectual Property Law, for IBM Corporation. Based in Armonk, New York, […]

Today’s article looks at the life and practicalities of the Australian Innovation Patent system. Filing An innovation application can also be filed as a Paris Convention application, for example as an application claiming priority from a US provisional or non provisional utility application, or as a stand alone application, thus establishing its own priority date, […]

The Australian Patent Office has handed down a significant decision in the land down under, which impacts the type of pharmaceutical subject matter that is eligible for term extension. N.V. Organon [2009] APO 8. According to Section 70 of the Australian Patent Statute, in order to be eligible for an extension of term, either or […]

Mylan Labs cried foul after getting stuck with the tab for almost $1.3 million in translation costs by Daiichi Pharma. A district court said Mylan had to pay under 28 U.S.C. § 1920 and Federal Rule of Civil Procedure 54(d). The U.S. Court of Appeals for the Federal Circuit agreed and said pay up. Ortho-McNeil […]

The US Patent & Trademark Office has released a beta test of its new web site. The beta site has a cleaner look than the original and should make navigation a little easier.  From the press release: The new site has been redesigned to improve the look and feel, as well as to enhance the […]

Patenting Genes WAMU Radio Station (88.5 FM) hosted a segment with Rebecca Roberts on patenting  gene-related products. The biotechnology industry says these patents are necessary to spur innovation. Opponents say they actually stifle science. We examine the intersection of cutting-edge genetic research and intellectual property. Guests included Hans Sauer, Associate General Counsel for Intellectual Property, […]

Abbott is the exclusive licensee of a patent for crystalline cefdinir, which it sells under the trade name Omnicef. Unfortunately, it hasn’t been able to catch a break. In dueling district court cases, the Eastern District of Virginia granted summary judgment of noninfringement for Lupin Pharma and the Illinois District Court denied a preliminary injunction […]